Impact of Clinical Pharmacy Services Provided for Patients With Active Rheumatoid Arthritis

NCT ID: NCT03743181

Last Updated: 2020-01-13

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 54 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2018-01-14
• Study Completion Date: 2019-12-18

Brief Summary

Enrolment of clinical pharmacy services in RA patients as a part of health care system has been investigated at many studies but not investigated in active RA patients before. This study aimed to detect drug therapy-related problems (DTRPs) in active rheumatoid arthritis (RA) patients and Investigate the impact of clinical pharmacist interventions on the patient clinical outcome and quality of life (QoL). Methods:Prospective, randomized controlled study to be carried out at rheumatology outpatient clinic, Ain Shams University Hospitals on 50 patients with active RA for 6 months.determine if any drug therapy problems are present.Develop a plan of care that includes interventions to resolve drug therapy problems, achieve goals of therapy, and prevent drug therapy problems. questionnaires was used to measure functional status in RA patients using health assessment questionnaire (HAQ) and assess self-reported quality of life in patients with (RA) using rheumatoid arthritis quality of life questionnaire (RAQOL) and measure adherence using the 4-item Morisky Green Levine Medication Adherence Scale and Disease Activity Score-28 was used as an objective method to assess RA disease activity.

Conditions

Rheumatoid Arthritis

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

intervention

will be supplied by pharmaceutical care services provided by the clinical pharmacist plus standard care by physician in attendance.

pharmaceutical care services

Intervention Type: OTHER

detection of drug therapy problems and investigation of the impact of clinical pharmacist interventions on the patient clinical outcome and quality of life

control

will received standard care by physician in attendance

No interventions assigned to this group

Interventions

pharmaceutical care services

detection of drug therapy problems and investigation of the impact of clinical pharmacist interventions on the patient clinical outcome and quality of life

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patients aged 18-60 years old
• fulfillment of the American College of Rheumatology /European league against rheumatism (2010 ACR/EULAR ) diagnostic criteria for RA.
• patients with active RA(defined by DAS28 score < 5.1)

Exclusion Criteria

• Patients with cognitive impairment.
• The presence of hepatic or renal disease.
• The presence of other rheumatic and connective tissue disorders.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 60 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

hager omar mohammed siddik

OTHER

Sponsor Role: lead

Responsible Party

hager omar mohammed siddik

Teaching assistant at clinical pharmacy department at faculty of pharmacy ain shams university

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

hager omar m siddik

Role: PRINCIPAL_INVESTIGATOR

teaching assistant at faculty of pharmacy ain shams university

Locations

Facuty of Pharmacu Ain Shams University

Cairo, Abasiya, Egypt

Countries

Egypt

Other Identifiers

156

Identifier Type: -

Identifier Source: org_study_id